Actionable Insights for Successful Development of Cell and Gene Therapies

Read the Case Study

A clinical-stage biotechnology start-up asked Veristat to run complex US and EU trials of their unique gene therapy. Veristat brought invaluable global capabilities and expertise to a small client team tackling their first clinical-stage program without the large infrastructure or resources to conduct studies in this space themselves. Our end-to-end full service support helped to successfully usher a program through the entire clinical development life cycle, from Phase 1 through to BLA submission.